Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Thyroid Diseases 1Parathyroid Diseases 1Neurilemmoma 1Neoplasms 1Meningioma 1Lung Neoplasms 1Low Grade Glioma of Brain 1Liver Neoplasms 1Inflammatory Bowel Diseases 1Inflammation 1Glioma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 16pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Hyperspectral Imaging × Clear all
NCT04712214 2023-04-25

Use of Non-invasive Optical Analysis in Neurosurgery

Imperial College London

Phase NA Unknown
50 enrolled
CNS

Brain Neoplasms, Glioma, Meningioma, Neurilemmoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡